Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions

Impact of aerobic exercise capacity and procedure-related factors in lung cancer surgery

M. Licker, J-M. Schnyder, J-G. Frey, J. Diaper, V. Cartier, C. Inan, J. Robert, P-O. Bridevaux, J-M. Tschopp
European Respiratory Journal 2011 37: 1189-1198; DOI: 10.1183/09031936.00069910
M. Licker
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: licker-marc-joseph@diogenes.hcuge.ch
J-M. Schnyder
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J-G. Frey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J. Diaper
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
V. Cartier
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
C. Inan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J. Robert
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
P-O. Bridevaux
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J-M. Tschopp
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Figures

  • Tables
  • Figure 1–
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1–

    Flow chart of patients operated for lung cancer and stratified according to pre-operative peak oxygen uptake (V′O2) values. Post-operative morbidity data are expressed as n (%). FEV1: forced expiratory volume in 1 s; CPET: cardiopulmonary exercise testing.

  • Figure 2–
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2–

    Stratification of post-operative outcome according to peak oxygen uptake (V′O2) values expressed as mL·kg−1·min−1. Incidence of cardiac, pulmonary and total cardiopulmonary complications during the hospital stay following surgery.

Tables

  • Figures
  • Table 1– Baseline characteristics stratified by peak oxygen uptake (V′O2)
    CharacteristicsV′O2 mL·min−1·kg−1p-value
    ≤1011– <1717– <20≥20
    Patients n29905239
    Age yrs68±1065±964±953±110.022
    BMI kg·m−228.4±5.125.5±4.624.8±5.823.9±4.70.009
    Males18 (62)61 (68)36 (69)30 (76)0.023
    ASA risk classes 3 and 414 (48)39 (43)21 (40)6 (15)0.011
    Smoking status
     Unit pack-yrs46±2442±2143±2044±220.652
     Current smoker18 (62)59 (66)32 (62)24 (62)0.712
     Ex-smoker#4 (14)10 (11)6 (12)4 (10)0.694
    Alcohol status4 (14)17 (19)9 (17)1 (13)0.751
    Coronary artery disease3 (10)7 (8)4 (8)2 (5)0.854
    Hypertension13 (45)35 (39)16 (31)7 (18)0.004
    Hypercholesterolaemia5 (17)21 (23)12 (23)4 (10)0.324
    Diabetes mellitus1 (3.4)9 (10)4 (8)3 (8)0.852
    Haematocrit45 (20)42 (6)42 (4)45 (20)0.325
    Creatinine clearance mL·min−186±2379±2979±3082±270.309
    FEV1 % pred65±1979±2282±2588±21<0.001
    ppo FEV1 % pred50±1955±2058±1764±19<0.001
    DL,CO % pred64±1674±17NANA
    ppo DL,CO % pred51±1059±18NANA
    V′O2,max mL−1·kg−19.0±1.613.7±1.217.6±1.124.4±4.6<0.001
    V′O2,max mL−1·kg−1 PBW11.6±2.915.8±3.120±3.625.4±5.4<0.001
    V′O2,max % pred39±1152±1365±1476±16<0.001
    Load W83±3293±23113±27137±36<0.001
    V′E,max L·min−137±1048±1157±1668±15<0.001
    V′E,max % pred75±1578±1789±1799±17<0.001
    Pa,O2 end exercise mmHg63±1866±2273±1274±16<0.001
    Neoadjuvant chemotherapy4 (14)12 (13)6 (12)6 (15)0.534
    Pathological stages Ia and Ib16 (55)37 (41)20 (38)12 (31)0.021
    Pneumonectomy or bilobectomy5 (17)16 (18)13 (25)5 (13)0.458
    • Data are presented as mean±sd or n (%), unless otherwise stated. BMI: body mass index; ASA: American Society Association; FEV1: forced expiratory volume in 1 s; ppo: predicted post-operative; DL,CO: diffusing capacity of the lung for carbon monoxide; V′O2,max: maximal oxygen uptake; PBW: predicted body weight; V′E,max: minute ventilation during maximal exercise; Pa,O2: arterial oxygen pressure; % pred: % predicted; NA: not available. #: >6 months smoking cessation.

  • Table 2– Clinical and surgical characteristics of patients with and without complications
    Total morbidityCardiovascular complicationsRespiratory complications
    YesNoYesNoYesNo
    Pre-operative period
    Patients n461642418628182
    Age yrs66±962±1169±962±8#65±963±11
    BMI kg·m−226.4±6.025.1±4.825.7±4.525.4±5.227.0±6.8#25.2±4.8
    Males34 (74)110(67)19 (79)125 (67)21 (72)144 (80)
    ASA classes 3 and 422 (48)58 (35)13 (54)67 (36)15 (53)80 (44)
    Smoking status
     Unit pack-yrs44±2142±2345±2341±2446±2343±21
     Current smoker32 (69)101(62)17 (71)116 (62)20 (71)113 (62)
     Ex-Smoker#6 (13)18 (11)3 (12)21 (11)3 (11)21 (12)
    Alcohol status8 (17)23 (14)4 (17)27 (14)6 (21)25 (14)
    Coronary artery disease6 (13.0)11 (6.7)3 (12.5)14 (7.5)3 (10.7)17 (9.4)
    Hypertension21 (46)51 (31)13 (54)59 (32)13 (46)72 (40)
    Hyperlipidaemia11 (24)32 (20)8 (33)35 (19)4 (14)43 (24)
    Diabetes mellitus2 (4.3)15 (9.1)1 (4.2)16 (8.6)2 (7.1)17 (9.4)
    FEV1 % pred77±2380±2378±2280±2374±2280±23
    ppo FEV1 % pred56±1861±2155±1661±1954±15#62±17
    Hematocrit40.3 (6.7)41.9 (4.4)38.5 (6.4)#42.1 (4.6)41.4 (7.5)41.6 (4.6)
    Creatinine clearance mL·min−180±3384±2573±18#85±2778±3782±25
    V′O2,max mL·min−1.kg−113.0±4.4#16.9±5.213.0±4.316.5±5.315.2±6.3#18.5±5.6
    V′O2,max mL·min−1·kg−1 PBW15.0±5.5#18.9±5.614.3±4.0#18.6±5.812.7±4.6#16.6±5.2
    V′O2,max % pred50±17#60±1750±14#59±1849±20#59±17
    Load W90±30#109±3489±35#107±3387±26#108±34
    V’E,max L.min−147±17#54±1648±1853±1646±15#53±16
    V′E,max %pred60±2165±1765±2764±1656±12#65±18
    Pa,O2 end exercice mmHg64±2170±1858±24#70±1767±2069±18
    Intra-operative period
    Surgical time min111±42#97±29123±42#97±30109±4199±31
    Anaesthesia time min152±64#123±35160±52#125±42154±74#125±37
    Pneumonectomy or bilobectomy12 (26)27 (16)10 (42)*29 (15)6 (21)33 (18)
    VT during TLV mL·kg−1 PBW8.1±2.37.4±2.17.9±2.37.6±2.28.8±1.9#6.9±2.0
    VT during OLV mL·kg−1 PBW6.9±2.26.5±2.17.0±2.96.4±2.77.0±1.9#5.6±1.8
    Phenylephrine mg580±442#384±348597±524#405±348635±431#397±358
    Fluid mL·kg−1·h−19.6±5.98.8±3.59.4±7.18.9±3.69.1±4.18.9±4.2
    • Data are presented as mean±sd or n (%), unless otherwise stated. BMI: body mass index; ASA: American Society Association; FEV1: forced expiratory volume in 1 s; ppo: predicted post-operative; V′O2,max: maximal oxygen uptake; PBW: predicted body weight; V′E,max: minute ventilation during maximal exercise; Pa,O2: arterial oxygen pressure; % pred: % predicted; VT: tidal volume; TLV: two-lung ventilation; OLV: one-lung ventilation. #: quit smoking >6 months ago.

  • Table 3– Characteristics of the four patients who died within the perioperative period
    PatientAge yrsSexBMI kg·m−2OperationComorbiditiesPeak V′O2 mL·kg−1·min−1#Peak V′O2 % predppo FEV1 % predCause of death
    182M28.7RULAlcohol¶8.24163Stroke (day 6)
    261M26.3LPCAD Hyperlipidaemia8.43145Myocardial infarction, stent thrombosis, heart failure (day 10)
    357F27.9RPHypertension Alcohol¶9.13239ALI, MOF (day 9)
    468M27.2LULHypertension Hyperlipidaemia Alcohol¶13.64962Pulmonary thrombo-embolism (day 4)
    • BMI: body mass index; M: male; F: female; V′O2 : oxygen uptake; ppo: predicted post-operative; FEV1: forced expiratory volume in 1 s ; RUL: right upper lobectomy; LP: left pneumonectomy; CAD: coronary artery disease; RP: right pneumonectomy; ALI: acute lung injury; MOF: multiple organ failure; LUL: left upper lobectomy. #: expressed in mL·min−1·kg−1 absolute body weight; ¶: alcohol: >21 drinks per week for men or >14 drinks per week for women.

  • Table 4– Results of logistic regression analysis for different dependent variables
    Independent predictorCoefficientsemOR (95% CI)p-valueBootstrap frequency %
    Total morbidity
     Constant0.298079
     Duration of anaesthesia0.01450.00411.015 (1.006–1.023)0.0005
     Peak V′O2 in mL·min−1·kg−1-0.23530.05460.79 (0.71–0.88)<0.000181
    Cardiovascular complications
     Constant-6.5727
     Age0.08040.03181.084 (1.018–1.153)0.011562
     Duration of anaesthesia0.01430.00451.014 (1.005–1.024)0.001672
     Pneumonectomy or bilobectomy1.75180.56745.76 (1.90–17.53)0.002071
     Peak V′O2 mL·min−1·kg−1-0.22860.07680.80 (0.68–0.92)0.002969
    Pulmonary complications
     Constant-21.0904
     Duration of anaesthesia0.01330.00421.013 (1.005–1.022)0.03266
     Peak V′O2 mL·min−1·kg−1-0.17520.05900.840 (0.749–0.942)0.02170
     VT mL·kg−1 PBW2.82490.53841.65 (1.27–4.49)0.00377
    • V′O2: oxygen uptake; VT: tidal volume; PBW: predicted body weight.

  • Table 5– Areas under the receiver operating characteristic curves and cut-off values of various parameters for the prediction of cardiovascular and pulmonary complications
    Area under the curveseLower–upper boundp-valueCut-offSensitivity %Specificity %
    Total morbidity
     V′O2 kg−10.7170.0450.651–0.7770.000112.85185
     V′O2 kg−1 PBW0.7100.0450.643–0.7710.000115.86469
     V′O2% pred0.6570.0450.589–0.7220.0010587548
     ASA score0.5930.0390.523–0.6610.015637148
     ppo FEV10.5650.0450.495–0.6330.7880646549
    Cardiovascular complications
     V′O2 kg−10.7080.0650.640–0.7710.001113.66372
     V′O2 kg−1 PBW0.7380.0540.671–0.7980.000116.27561
     V′O2% pred0.6330.0610.562–0.7000.0029536461
     ASA score0.6300.0460.560–0.6950.008037947
     ppo FEV1% pred0.4920.0660.422–0.5620.9030802979
    Pulmonary complications
     V′O2 kg−10.7230.0570.654–0.7840.000112.35686
     V′O2 kg−1 PBW0.6910.0650.580–0.7180.002012.14594
     V′O2% pred0.6160.0660.544–0.6840.0169373095
     ASA score0.5970.0440.527–0.6640.026937347
     ppo FEV10.5450.0510.480–0.6140.3716647350
    • V′O2: oxygen uptake; PBW: predicted body weight; % pred: % predicted; ASA: American Society Association; FEV1: forced expiratory volume in 1 s; ppo: predicted post-operative.

PreviousNext
Back to top
View this article with LENS
Vol 37 Issue 5 Table of Contents
European Respiratory Journal: 37 (5)
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Impact of aerobic exercise capacity and procedure-related factors in lung cancer surgery
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
Impact of aerobic exercise capacity and procedure-related factors in lung cancer surgery
M. Licker, J-M. Schnyder, J-G. Frey, J. Diaper, V. Cartier, C. Inan, J. Robert, P-O. Bridevaux, J-M. Tschopp
European Respiratory Journal May 2011, 37 (5) 1189-1198; DOI: 10.1183/09031936.00069910

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Impact of aerobic exercise capacity and procedure-related factors in lung cancer surgery
M. Licker, J-M. Schnyder, J-G. Frey, J. Diaper, V. Cartier, C. Inan, J. Robert, P-O. Bridevaux, J-M. Tschopp
European Respiratory Journal May 2011, 37 (5) 1189-1198; DOI: 10.1183/09031936.00069910
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
    • MATERIAL AND METHODS
    • RESULTS
    • DISCUSSION
    • APPENDIX: MAJOR OUTCOMES
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Subjects

  • Lung cancer
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

Original Article

  • Lung volumes and survival in chronic lung allograft dysfunction
  • EBUS-guided cryobiopsies in peripheral pulmonary lesions
  • Safety of formoterol in asthma clinical trials
Show more Original Article

Thoracic Oncology

  • Non-inferiority trials in advanced NSCLC
  • The lung cancer patient, the pneumologist and palliative care
  • thoracic oncology
Show more Thoracic Oncology

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Reviewers
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society